Levagen+™ PEA: With FDA status of CBD still in limbo, brands are looking to legal CBD alternatives to help address common health concerns. Palmitoylethanolamide (PEA), known as our internal endocannabinoid, works on similar pathways as CBD to help minimize pain associated with joint health, aid sports-related inflammation and promote more restful sleep.
Hear R.V. Venkatesh, Managing Director for Gencor™, discuss the benefits of Levagen PEA vs. CBD.
Visit https://gencorpacific.com/featured-ingredients/levagen to learn more.